Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Contrast Media & Molecular Imaging|May 11, 2022
Contrast-Enhanced Ultrasonography for Differential Diagnosis of Benign and Malignant Thyroid Lesions: Single-Institutional Prospective Study of Qualitative and Quantitative CEUS CharacteristicsHana Petrasova, Radka Slaisova, Tomas Rohan, et al.
Biomed Research International|September 23, 2014
Different clinical utility of oropharyngeal bacterial screening prior to percutaneous endoscopic gastrostomy in oncological and neurological patientsRadek Kroupa, Jana Jurankova, Milan Dastych, et al.
Experimental Hematology|August 6, 2009
Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patientsAndrea Janikova, Zdenek Koristek, Jaroslava Vinklarkova, et al.
Cancer Epidemiology|November 8, 2020
Incidence trends of esophageal cancer in the Czech Republic by histological subtype and stage and prescription rate of acid suppressing drugsRadek Kroupa, Ivana Katinova, Tomas Pavlik, et al.
BMC Medical Imaging|June 20, 2020
Prospective evaluation of contrast-enhanced ultrasound of breast BI-RADS 3-5 lesionsEva Janu, Lucie Krikavova, Jirina Little, et al.
Urologic Oncology|December 11, 2013
Clinical and laboratory prognostic factors in patients with metastatic renal cell carcinoma treated with sunitinib and sorafenib after progression on cytokinesAlexandr Poprach, Tomas Pavlik, Bohuslav Melichar, et al.
BMC Gastroenterology|March 27, 2014
Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registryLubomir Slavicek, Tomas Pavlik, Jiri Tomasek, et al.
BMC Gastroenterology|April 19, 2015
Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical viewBeatrix Bencsikova, Zbynek Bortlicek, Jana Halamkova, et al.
Targeted Oncology|April 24, 2015
Comparison of Two Prognostic Models in Patients with Metastatic Renal Cancer Treated with Sunitinib: a Retrospective, Registry-Based StudyKaterina Kubackova, Bohuslav Melichar, Zbynek Bortlicek, et al.
BMC Cancer|June 3, 2014
Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysisTomas Buchler, Tomas Pavlik, Bohuslav Melichar, et al.
Pageof 3